Press

New study by MIT Sloan researchers provides insights on the challenges of developing drugs for pediatric cancer—and offers a potential solution 

Study suggests that a collaborative investment approach between public and private institutions could greatly accelerate innovation.

Jun 2, 2018
Read Article
Press

Measuring the risks and rewards of drug development: New research from MIT shows that the success rates of clinical trials are higher than previously thought

The study has broad implications for investors, regulators, policymakers, and clinicians

Jan 31, 2018
Read Article
Load More